Search Results
Departamento de Tecnología Médica, Facultad de Medicina, Universidad de Chile, Santiago, Chile
Search for other papers by Verónica A Bahamondes Lorca in
Google Scholar
PubMed
Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio, USA
Search for other papers by Shiyong Wu in
Google Scholar
PubMed
hormone, and how this hormone induces radioresistance due to an increase in the capacity of cellular DNA repair. Radiation therapy of the hypothalamic–pituitary area and growth hormone deficiency Radiotherapy and growth hormone deficiency The
Search for other papers by Reetobrata Basu in
Google Scholar
PubMed
Molecular and Cellular Biology Program, Ohio University, Athens, Ohio, USA
Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA
Search for other papers by John J Kopchick in
Google Scholar
PubMed
poorer response to therapy associated with higher GHR expression ( Wu et al. 2006 ). The major underlying mechanisms of GH-induced radio-resistance, as recently described by Melmed and colleagues, largely lie in radiation-induced DNA damage, leading to
The Liggins Institute, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, Cancer Science Institute of Singapore and Department of Pharmacology, University of Auckland, 2-6 Park Avenue, Private Bag 92019, Auckland 1023, New Zealand
Search for other papers by Nicola M Bougen in
Google Scholar
PubMed
Search for other papers by Michael Steiner in
Google Scholar
PubMed
Search for other papers by Mikhail Pertziger in
Google Scholar
PubMed
Search for other papers by Arindam Banerjee in
Google Scholar
PubMed
Search for other papers by Severine E Brunet-Dunand in
Google Scholar
PubMed
Search for other papers by Tao Zhu in
Google Scholar
PubMed
The Liggins Institute, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, Cancer Science Institute of Singapore and Department of Pharmacology, University of Auckland, 2-6 Park Avenue, Private Bag 92019, Auckland 1023, New Zealand
Search for other papers by Peter E Lobie in
Google Scholar
PubMed
Search for other papers by Jo K Perry in
Google Scholar
PubMed
growth factor receptor (HER) family have been demonstrated to promote radioresistance through multiple mechanisms ( Jameel et al . 2004 , Dumont et al . 2009 , Zaidi et al . 2009 ). Accumulating evidence indicates a role for human GH (hGH) in human
Search for other papers by Chun-Te Wu in
Google Scholar
PubMed
Search for other papers by Wen-Cheng Chen in
Google Scholar
PubMed
Search for other papers by Shuen-Kuei Liao in
Google Scholar
PubMed
Search for other papers by Cheng-Lung Hsu in
Google Scholar
PubMed
Search for other papers by Kuan-Der Lee in
Google Scholar
PubMed
Search for other papers by Miao-Fen Chen in
Google Scholar
PubMed
that concurrent androgen deprivation failed to radiosensitize 22RV1 cells. In contrast, HR cells induced by long-term androgen deprivation had significantly greater radioresistance when compared with control cells, which was noted in both 22RV1 and
Search for other papers by Olga Lakiza in
Google Scholar
PubMed
Search for other papers by Julian Lutze in
Google Scholar
PubMed
Search for other papers by Alyx Vogle in
Google Scholar
PubMed
Search for other papers by Jelani Williams in
Google Scholar
PubMed
Search for other papers by Abde Abukdheir in
Google Scholar
PubMed
Search for other papers by Paul Miller in
Google Scholar
PubMed
Search for other papers by Chih-Yi ‘Andy’ Liao in
Google Scholar
PubMed
Search for other papers by Sean P Pitroda in
Google Scholar
PubMed
Search for other papers by Carlos Martinez in
Google Scholar
PubMed
Search for other papers by Andrea Olivas in
Google Scholar
PubMed
Search for other papers by Namrata Setia in
Google Scholar
PubMed
Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois, USA
Search for other papers by Stephen J Kron in
Google Scholar
PubMed
Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois, USA
Search for other papers by Ralph R Weichselbaum in
Google Scholar
PubMed
Search for other papers by Xavier M Keutgen in
Google Scholar
PubMed
specific mechanisms remain to be determined. Treating tumors with ionizing radiation (IR) using external beam radiation (EBRT) can control the local progression of many cancers. While anecdotal observations of radioresistance in neuroendocrine tumors
Search for other papers by J M Gee in
Google Scholar
PubMed
Search for other papers by J F Robertson in
Google Scholar
PubMed
Search for other papers by E Gutteridge in
Google Scholar
PubMed
Search for other papers by I O Ellis in
Google Scholar
PubMed
Search for other papers by S E Pinder in
Google Scholar
PubMed
Search for other papers by M Rubini in
Google Scholar
PubMed
Search for other papers by R I Nicholson in
Google Scholar
PubMed
, it has been reported that increased IGF-1R signalling occurs in acquired radioresistance ( Turner et al. 1997 ). If our clinical results are considered alongside the limited model system data, the importance of IGF-1R signalling to ER + or ER
Search for other papers by Adly Yacoub in
Google Scholar
PubMed
Search for other papers by Anna Miller in
Google Scholar
PubMed
Search for other papers by Ruben W Caron in
Google Scholar
PubMed
Search for other papers by Liang Qiao in
Google Scholar
PubMed
Search for other papers by David A Curiel in
Google Scholar
PubMed
Search for other papers by Paul B Fisher in
Google Scholar
PubMed
Search for other papers by Michael P Hagan in
Google Scholar
PubMed
Search for other papers by Steven Grant in
Google Scholar
PubMed
Search for other papers by Paul Dent in
Google Scholar
PubMed
also promote radioresistance by loss of p53-induced apoptosis after DNA damage. To further investigate the relative roles of ERBB1 and ERBB2 in HCT116 cell signaling after radiation exposure, cells were incubated with the ERBB1 inhibitor AG1478
Search for other papers by Xi Zhang in
Google Scholar
PubMed
Search for other papers by Vijay Pandey in
Google Scholar
PubMed
Search for other papers by Vipul Bhardwaj in
Google Scholar
PubMed
Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P R China
The CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P R China
Search for other papers by Tao Zhu in
Google Scholar
PubMed
Tsinghua Berkeley Shenzhen Institute and Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, P R China
Search for other papers by Peter E Lobie in
Google Scholar
PubMed
Growth in 3D Matrigel ( Bougen et al. 2011 ) Primary mammary carcinoma cells JAK2 – Cell viability ( Chiesa et al. 2011 ) MDA-MB-435S T47D JAK2/c-SRC BRCA2 XRCC2 hTERT Radioresistance Total cell number Cell survival
Search for other papers by Andrea Weckman in
Google Scholar
PubMed
Search for other papers by Fabio Rotondo in
Google Scholar
PubMed
Search for other papers by Antonio Di Ieva in
Google Scholar
PubMed
Search for other papers by Luis V Syro in
Google Scholar
PubMed
Search for other papers by Henriett Butz in
Google Scholar
PubMed
Search for other papers by Michael D Cusimano in
Google Scholar
PubMed
Search for other papers by Kalman Kovacs in
Google Scholar
PubMed
- and radioresistance respectively ( Lin et al . 2009 ). Moreover, the use of RAD001, an mTOR inhibitor that induces autophagy in PTC cells, in conjunction with doxorubicin or external beam radiation, increased their anticancer effects ( Lin et al
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Institute of Medical Science
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Eric Monsalves in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Kyle Juraschka in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Toru Tateno in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Sameer Agnihotri in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Sylvia L Asa in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Institute of Medical Science
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Institute of Medical Science
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Shereen Ezzat in
Google Scholar
PubMed
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Institute of Medical Science
Department of Medical Biophysics University of Toronto, Toronto, Ontario, Canada
Division of Neurosurgery Toronto Western Hospital, 399 Bathurst Street, 4W-439, Toronto, Ontario, Canada M5T 2S8
Ontario Cancer Institute Princess Margaret Hospital, Toronto, Ontario, Canada
Endocrine Oncology Site Group Princess Margaret Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
Search for other papers by Gelareh Zadeh in
Google Scholar
PubMed
inhibition may also lead to decreased radioresistance of PA cells in vitro . Sukumari-Ramesh et al . (2011) report that inhibition of mTOR radiosensitizes GH3 cells such that 2.5 Gy in combination with 0.5 nM rapamycin or RAD001 reduced cellular viability